Persistent URL of this record https://hdl.handle.net/1887/119992
In Collections
This item can be found in the following collections:
![Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis
- All authors
- Quistrebert, J.; Hassler, S.; Bachelet, D.; Mbogning, C.; Musters, A.; Tak, P.P.; Wijbrandts, C.A.; Herenius, M.; Bergstra, S.A.; Akdemir, G.; Johannesson, M.; Combe, B.; Fautrel, B.; Chollet-Martin, S.; Gleizes, A.; Donnellan, N.; Deisenhammer, F.; Davidson, J.; Hincelin-Mery, A.; Donnes, P.; Fogdell-Hahn, A.; Vries, N. de; Huizinga, T.; Abugessaisa, I.; Saevarsdottir, S.; Hacein-Bey-Abina, S.; Pallardy, M.; Broet, P.; Mariette, X.; ABIRISK Consortium
- Date
- 2019-06-30
- Volume
- 48
- Issue
- 6
- Pages
- 967 - 975